【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 7
2 Introduction 8
2.1 Metabolite Chemistry Reagents Overview 8
3 Products under Development 9
3.1 Metabolite Chemistry Reagents – Pipeline Products by Stage of Development 9
3.2 Metabolite Chemistry Reagents – Pipeline Products by Territory 10
3.3 Metabolite Chemistry Reagents – Pipeline Products by Regulatory Path 11
3.4 Metabolite Chemistry Reagents – Pipeline Products by Estimated Approval Date 12
3.5 Metabolite Chemistry Reagents – Ongoing Clinical Trials 13
4 Metabolite Chemistry Reagents – Pipeline Products under Development by Companies 14
4.1 Metabolite Chemistry Reagents Companies – Pipeline Products by Stage of Development 14
4.2 Metabolite Chemistry Reagents – Pipeline Products by Stage of Development 16
5 Metabolite Chemistry Reagents Companies and Product Overview 18
5.1 A/C Diagnostics LLC Company Overview 18
5.1.1 A/C Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 18
5.2 Abbott Diagnostics Company Overview 20
5.2.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 20
5.3 Alfa Wassermann Diagnostic Technologies, LLC Company Overview 22
5.3.1 Alfa Wassermann Diagnostic Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 22
5.4 Analyticon Biotechnologies AG Company Overview 25
5.4.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 25
5.5 Axis-Shield Limited (Inactive) Company Overview 51
5.5.1 Axis-Shield Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 51
5.6 Beckman Coulter, Inc. Company Overview 52
5.6.1 Beckman Coulter, Inc. Pipeline Products & Ongoing Clinical Trials Overview 52
5.7 BG Medicine, Inc. Company Overview 53
5.7.1 BG Medicine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
5.8 Boulder Diagnostics Inc. Company Overview 54
5.8.1 Boulder Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 54
5.9 Consejo Superior de Investigaciones Cientificas Company Overview 55
5.9.1 Consejo Superior de Investigaciones Cientificas Pipeline Products & Ongoing Clinical Trials Overview 55
5.10 Genesis Detection Systems, Inc. Company Overview 56
5.10.1 Genesis Detection Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56
5.11 Healthmed Services Ltd. Company Overview 57
5.11.1 Healthmed Services Ltd. Pipeline Products & Ongoing Clinical Trials Overview 57
5.12 Illumina, Inc. Company Overview 58
5.12.1 Illumina, Inc. Pipeline Products & Ongoing Clinical Trials Overview 58
5.13 Instrumentation Laboratory Company Company Overview 63
5.13.1 Instrumentation Laboratory Company Pipeline Products & Ongoing Clinical Trials Overview 63
5.14 iXensor Co. Ltd. Company Overview 64
5.14.1 iXensor Co. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 64
5.15 Miraculins Inc. Company Overview 65
5.15.1 Miraculins Inc. Pipeline Products & Ongoing Clinical Trials Overview 65
5.16 Molecular Biometrics, LLC. Company Overview 69
5.16.1 Molecular Biometrics, LLC. Pipeline Products & Ongoing Clinical Trials Overview 69
5.17 Ohmx Corporation Company Overview 70
5.17.1 Ohmx Corporation Pipeline Products & Ongoing Clinical Trials Overview 70
5.18 Oxford Immunotec Limited Company Overview 71
5.18.1 Oxford Immunotec Limited Pipeline Products & Ongoing Clinical Trials Overview 71
5.19 Randox Laboratories Limited Company Overview 72
5.19.1 Randox Laboratories Limited Pipeline Products & Ongoing Clinical Trials Overview 72
5.20 Sekisui Medical Co., Ltd. Company Overview 73
5.20.1 Sekisui Medical Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 73
5.21 SenGenix, Inc. Company Overview 75
5.21.1 SenGenix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
5.22 Siemens Healthcare Diagnostics Inc. Company Overview 76
5.22.1 Siemens Healthcare Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 76
5.23 The Binding Site Group Ltd. Company Overview 78
5.23.1 The Binding Site Group Ltd. Pipeline Products & Ongoing Clinical Trials Overview 78
5.24 Vital Diagnostics, Inc. Company Overview 79
5.24.1 Vital Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 79
6 Metabolite Chemistry Reagents- Recent Developments 81
7 Appendix 86
7.1 Methodology 86
7.2 About GlobalData 88
7.3 Contact Us 89
7.4 Disclaimer 89
【レポート販売概要】
■ タイトル：世界における代謝物化学試薬の製品パイプライン動向2015■ 英文：Metabolite Chemistry Reagents - Pipeline Review, 2015
■ 発行日：2015年10月1日
■ 調査会社：GlobalData
■ 商品コード：GDME0085EPD
■ 調査対象地域：グローバル
- モバイル決済：旅行者、銀行口座ない人、無/低信用者（Mobile Payments: The Market for Travelers, Unbanked, and No/Low Credit Users）A significant portion of the global population is “unbanked”, low credit, or otherwise unable to establish and maintain a bank account. While this portion of the population is on a downtrend due to globalization and developing countries becoming more industrialized, the market segment without a traditional financial account is an important market segment for mobile commerce. In addition, travelers …
- 世界の染料及び有機顔料市場2015The Global Dyes & Organic Pigments Industry Report 2015 is a professional and in-depth study on the current state of the Dyes & Organic Pigments industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Dyes & Organic Pigments market analysis is provided for the international markets including development tr …
- 世界の黒色腫（メラノーマ）治療市場動向（2012-2016）TechNavio's analysts forecast the Global Melanoma Therapeutics market to grow at a CAGR of 15.83 percent over the period 2012-2016. One of the key factors contributing to this market growth is the availability of new promising drugs in the pipeline. The Global Melanoma Therapeutics market has also been witnessing the increasing use of combination therapies for the treatment of melanoma. However, t …
- フリークエントフライヤー向けクレジットカードのベストプラクティスThe report provides information and insights on into market trends for credit cards targeted at frequent flyers, including: • A global snapshot of frequent flyer credit card dynamics and market drivers. • Comprehensive analysis of key trends expected to shape the market over the next five years. • Analysis of industry best practice through detailed case studies. • Detailed analysis of key markets, …
- スーパー崩壊剤の世界市場：クロスカルメロースナトリウム、クロスポビドン、デンプングリコール酸ナトリウム、イオン交換樹脂The global superdisintegrants market is expected to reach USD 416.5 Million by 2021 from USD 286.8 Million in 2016, at a CAGR of 7.8% during the forecast period of 2016 to 2021. Growing generic drugs market, growing population of geriatric and paediatric patients, and emergence of new superdisintegrants for the pharmaceutical industry are factors driving the growth of the market. However, factors …
- 世界のマスターバッチ（樹脂用着色剤）市場：ブラック/ホワイト/カラー/添加剤マスターバッチAbout Masterbatch Masterbatches are additives or pigments, which are in concentrated form, used for coloring or imparting desired properties to polymers. Masterbatch allows the molder to improve the appearance and performance of the raw polymer or resin in a cost-effective manner during the plastics manufacturing process. They are broadly classified into four types: black, white, color, and additi …
- 重建設機械の世界市場予測（～2021）：種類別（陸上移動、マテリアルハンドリング、重工業車両）、最終用途産業別（建設・製造業、公共事業・鉄道、鉱業）、用途別、地域別“Heavy construction equipment market projected to grow at a CAGR of 7.0%” The heavy construction equipment market size is projected to grow at a CAGR of 7.0% during the forecast period of 2016 – 2021 and reach USD 180.66 billion by 2021. The heavy construction equipment market is gaining momentum in the modern construction industry due to factors such as geographical expansion in emerging markets …
- エビの世界市場：冷凍えび、エビ缶詰、その他Global Shrimp Market: About this market Shrimp is a good source of protein and vitamin D and is one of the most popular seafood consumed globally. Technavio’s shrimp market analysis considers sales from the frozen shrimp, canned shrimp, and other segments, through supermarkets and hypermarkets, convenience stores, and others. Our analysis also considers the sales of shrimp in APAC, Europe, MEA, No …
- Black River Electric Cooperative, Inc.：発電所及びSWOT分析2013Black River Electric Cooperative, Inc. - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (asset …
- アクアリウム用品の世界市場2016-2020About Fish Keeping Fish keeping is among the most popular of hobbies among millions of enthusiasts around the world. The US is the single largest importer of ornamental fish in the world. More than 2,500 marine fish species and 750 invertebrates have been imported into the US since 2000 to meet the demand of hobbyists in the country. Technavio’s analysts forecast the global aquarium accessories ma …
- Petoro AS：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Petoro AS Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Petoro AS Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operational dat …
- WAN（広域ネットワーク）最適化ソリューションの世界市場The increasing demand for cloud-based WAN optimizing solutions and the development of new datacenter and branch offices are driving the adoption of WAN optimization solutions. The highly distributed workforce of the enterprises worldwide and use of high bandwidth applications have unfolded a new level of bandwidth and network management requirement over WAN. There has been a significant adoption o …
- 多発性硬化症治療薬の世界市場2019-2023About this market Globally, the prevalence of multiple sclerosis has increased due to genetic and environmental factors. Another reason which could be attributed to the increasing prevalence is the advances in diagnostic techniques in this therapy area. The prevalence of autoimmune diseases such as type 1 diabetes and certain infections such as infectious mononucleosis also increases the risk of m …
- 白血病治療薬の世界市場：慢性リンパ性白血病、急性リンパ性白血病、急性骨髄性白血病、慢性骨髄性白血病About Leukemia Cancer that starts from hematopoietic stem cells of the bone marrow is referred to as leukemia. Leukemia can be chronic or acute depending on the maturity of the cells. Also, based on the bone marrow cells from which cancer starts, leukemia can be categorized as lymphocytic or myeloid. Technavio’s analysts forecast the leukemia therapeutics market to grow at a CAGR of 8.44% during t …
- Avonex (Multiple Sclerosis)：市場予測と分析（～2022）Avonex (Multiple Sclerosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Avonex (Multiple Sclerosis) - Forecast and Market Analysis to 2022”. Multiple sclerosis (MS) is a chronic, inflammatory neurological disorder characterized pathologically by demyelination, axonal transection and neurodegeneration within the central nervous …
